+239.5%
ZETA vs MRNA
-33.5%
+273.0%
-70.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | +5.4% | -6.6% | -1.7% |
| 7D | -3.7% | -1.1% | -2.6% | -3.7% |
| 30D | +5.7% | +126.1% | -120.4% | -9.8% |
| 3M | +50.4% | +190.0% | -139.6% | +21.2% |
| 6M | +65.5% | +157.2% | -91.8% | +35.8% |
| YTD | +48.3% | +388.2% | -339.9% | +5.4% |
| 1Y | +45.4% | +467.0% | -421.7% | -0.9% |
| 3Y | +270.8% | +36.1% | +234.7% | +210.6% |
| 5Y | +336.1% | -68.0% | +404.1% | +325.5% |
| All | +239.5% | -33.5% | +273.0% | +246.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling